Erratum: Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: a prospective observational study (British Journal of Anaesthesia (2016) 117(3) (309–315)(S000709121733790X)(10.1093/bja/aew189));Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: A prospective observational study

British Journal of Anaesthesia

Volumn 117, Issue 3, 2016, Pages 309-315

  Malm, C J ^a,b   Hansson, E C ^a,b   Akesson, J ^c   Andersson, M ^c   Hesse, C ^a   Shams Hakimi, C ^a,b   Jeppsson, A ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

acute coronary syndrome; blood platelets; cardiovascular surgery; haemorrhage; platelet function tests

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; HEPARIN; PROTAMINE SULFATE; THROMBIN RECEPTOR ACTIVATING PEPTIDE; TICAGRELOR; TRANEXAMIC ACID; ADENOSINE; PURINERGIC P2Y RECEPTOR ANTAGONIST;

ADULT; AGED; ARTICLE; BLOOD CLOTTING PARAMETERS; FEMALE; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OPERATIVE BLOOD LOSS; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; ANALOGS AND DERIVATIVES; DRUG EFFECT; MIDDLE AGED; PHYSIOLOGY; POSTOPERATIVE HEMORRHAGE; THROMBOCYTE; THROMBOCYTE TRANSFUSION; VERY ELDERLY;

ADENOSINE; ADENOSINE DIPHOSPHATE; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; CARDIAC SURGICAL PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET TRANSFUSION; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; PURINERGIC P2Y RECEPTOR ANTAGONISTS;

EID: 84995419062     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aex049     Document Type: Erratum

References (21)

1. Herman CR, Buth KJ, Kent BA, Hirsch GM. Clopidogrel increases blood transfusion and hemorrhagic complications in patients undergoing cardiac surgery. Ann Thorac Surg 2010; 89: 397-402
2. Hansson EC, Jidéus L, Åberg B, et al. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study. Eur Heart J 2016; 37: 189-97
3. Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2014; 35: 2541-619
4. Anderson JL, Adams CD, Antman EM, et al. 2012ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 61: e179-347
5. Ranucci M, Colella D, Baryshnikova E, Di Dedda U; Surgical and Clinical Outcome Research (SCORE). Group. Effect of preoperative P2Y12 and thrombin platelet receptor inhibition on bleeding after cardiac surgery. Br J Anaesth 2014; 113: 970-6
6. Held C, Åsenblad N, Bassand J-P, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes). trial. J Am Coll Cardiol 2011; 57: 672-84
7. Wallentin L. P2Y12 inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use. Eur Heart J 2009; 30: 1964-77
8. Fox KAA, Mehta SR, Peters R, et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE). Trial. Circulation 2004; 110: 1202-8
9. Smith PK, Goodnough LT, Levy JH, et al. Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-Adjusted retrospective data analysis. J Am Coll Cardiol 2012; 60: 388-96
10. Gurbel PA, Bliden KP, Butler K, et al. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation 2009; 120: 2577-85
11. Kwak Y-L, Kim J-C, Choi Y-S, Yoo K-J, Song Y, Shim J-K. Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery. J Am Coll Cardiol 2010; 56: 1994-2002
12. Mahla E, Suarez TA, Bliden KP, et al. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-Treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-Associated bleeding related to CABG (TARGET-CABG). study. Circ Cardiovasc Interv 2012; 5: 261-9
13. Ranucci M, Baryshnikova E, Soro G, Ballotta A, De Benedetti D, Conti D. Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines. Ann Thorac Surg 2011; 91: 123-9
14. Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol 2014; 64: e139-228
15. Roffi M, Patrono C, Collet J-P, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2016; 37: 267-315
16. Ternström L, Hyllner M, Backlund E, Schersten H, Jeppsson A. Astructured blood conservation programme reduces transfusions and costs in cardiac surgery. Interact CardioVasc Thorac Surg 2014; 19: 788-94
17. Dyke C, Aronson S, Dietrich W, Hofmann A, et al. Universal definition of perioperative bleeding in adult cardiac surgery. J Thorac Cardiovasc Surg 2014; 147: 1458-63
18. Tóth O, Calatzis A, Penz S, Losonczy H, SiessW. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 2006; 96: 781-8
19. Hansson EC, Shams Hakimi C, Åström-Olsson K, et al. Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelor. Br J Anaesth 2014; 112: 570-5
20. Storey RF, Bliden KP, Ecob R, et al. Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responses. J Thromb Haemost 2011; 9: 1730-7
21. Hanke AA, Roberg K, Monaca E, et al. Impact of platelet count on results obtained from multiple electrode platelet aggregometry (Multiplate). Eur J Med Res 2010; 15: 214-9